Insight, analysis & opinion from Joe Paduda
Here’s what happened last week… People who enroll in exchange programs in red states pay 3.2 percent more for their health insurance than folks in purple or blue states. Research indicates it is because fewer folks in red states sign … Continue reading Monday update – healthcare costs, guidelines, what docs want, and market consolidation
Read More...In which I attempt to describe the top takeaways from the latest research and what it may mean for you. Work comp pharmacy WCRI’s latest report on Interstate variations on Dispensing of Opioids is available; free for members, nominal cost … Continue reading Research Roundup
Read More...Happy Friday! It’s Research Roundup time. Here’s my quick takeaways on new research – and how it affects you. WCRI on the interaction of health insurance and workers’ comp Bogdan Savych PhD of WCRI has provided an excellent review of … Continue reading Worker outcomes, opioid reductions, and prices for drugs and hospitals
Read More...The 9 reasons I love CWCI’s annual conference. Consistently great content– timely, up-to-the minute data is analyzed and presented by experts who really understand the California work comp system, have deep experience in that system, and use that experience to … Continue reading Why I love the CWCI Conference
Read More...Buyers are asking healthcare intermediaries for “transparency”. We talked about why this is happening yesterday; today I’ll try to concisely describe what this transparency thing is. The emphasis on try is an upfront admission that a blog post is NOT … Continue reading What – exactly – is “transparency”?
Read More...So, hard as it is to believe, there was some non-Supreme Court hearing stuff going on this week. I know…I missed most of it too. So, here’s some of the most important research we all missed while overloading incoming web … Continue reading Research Roundup – Friday edition
Read More...There’s a bill in the US House of Representatives that would greatly expand compounding, drastically reduce the FDA’s ability to oversee compounding, and eliminate many of the desperately-needed controls on this occasionally-deadly and often-abused practice. Why anyone thinks this is … Continue reading Compounds – the stench of corruption
Read More...Work comp drug costs are down 22% over the last five years. Opioid spend dropped 16.7% last year. That’s the key takeaway from CompPharma’s annual survey of Prescription Drug Management in Workers’ Comp. These are truly remarkable results; payers and … Continue reading Comp is getting it done on opioids.
Read More...In the fourteen years I’ve been surveying work comp payers on their views on pharmacy, I’ve never seen so little consensus among respondents on emerging issues. In past years compounds, physician dispensing, opioids, price inflation, and new drug introductions have … Continue reading There’s no BIG problem in work comp pharmacy – and that’s scary.
Read More...now that repeal and replace is dead, we can figure out what we missed while contemplating healthcare armageddon. Workers’ comp WCRI’s been publishing a flurry of great reports on injured worker outcomes, physician dispensing, opioids, and hospital costs. Sign up … Continue reading Workers’ comp update
Read More...